Nuclera

Nuclera’s mission is to support scientists to better human health by enabling rapid access to proteins required for drug discovery research. The Company’s eProtein Discovery™ benchtop system accelerates protein expression and purification workflows within research labs.

The system reduces the timelines and costs associated with protein expression and purification through automated construct screening to inform protein scale-up resulting in mg amounts in less than 48 hours. Integrating digital microfluidics, protein quality assays, and cell-free protein synthesis on eProtein Discovery cartridges, eProtein Discovery enables rapid access to even challenging proteins at high quality.

Founded in 2013, Nuclera’s offices are located in Cambridge (UK) and Boston (US).

For more information please visit: www.nuclera.com